International Journal of Medical and Pharmaceutical Research
2023, Volume-4, Issue-5 doi: 10.5281/zenodo.8377235
Original Article
Clinical Profile of Benign Biliary Stricture In A Tertiary Care Center From Western India
 ,
 ,
 ,
 ,
 ,
 ,
 ,
 ,
Published
Sept. 23, 2023
Abstract

Objectives: Benign Biliary Stricture (BBS) often cause a significant amount of morbidity in patients due to its relatively painless course of progression and subtle clinical manifestations. This hospital-based study primarily focuses on BBS in Indian patients intending to find out its different etiologies and clinical manifestations; to observe clinical progression and response to the different treatments.

Materials and methods: Patients with age ≥18 years and diagnosed with benign biliary stricture were included in the study. Routine blood testing and special tests for tumor markers were done. Ultrasonography (USG), Contrast Enhanced Computed Tomography (CECT) abdomen, Magnetic Resonance Cholangio-pancreatography (MRCP), Endoscopic Ultrasound (EUS) and Endoscopic Retrograde Cholangio-pancreatography (ERCP) were performed for evaluation of BBS. The total number of stents used, stents exchanged and duration of use till the resolution of symptoms were noted.

Results: Out of 100 recruited patients, 56 were females and 44 were males with a mean age of 48.5 ± 14.96 years. Abdominal pain (90%), jaundice (42%) and fever (25%) were the most common clinical manifestations. Most of the BBS were of indeterminate cause (56%). Laparoscopic Cholecystectomy (LC) was the most common etiology in the remaining patients. The mean number of stent exchanges and mean number of stents used were 2.68±0.69 and 4.16±1.52 respectively. The average mean duration of stent use was found to be 8.77±2.02 months.

Conclusions:ERCP for the treatment of BBS should be preferred over surgery and the percutaneous approach due to its low invasiveness, because it is more patient friendly, safer and repeatable.

Recommended Articles
Loading Image...
Volume-4, Issue-5
Citations
714 Views
238 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved